106 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp00833 | AAP-H | YVPGP | Marine invertebrates | Apoptosis inducing | MTT assay | DU-145 | Prostate cancer | IC50 : 9.605 mM |
| dbacp00834 | AAP-H | YVPGP | Marine invertebrates | Apoptosis inducing | MTT assay | DU-146 | Prostate cancer | IC50 : 7.910 mM |
| dbacp00835 | AAP-H | YVPGP | Marine invertebrates | Apoptosis inducing | MTT assay | DU-147 | Prostate cancer | IC50 : 2.298 mM |
| dbacp01219 | ATP-binding cassette sub-family C member 5 | MKDIDMGKEYIIPSPGYRSVRDRSTIPGTHGDREDPSSGEQISLECQDALETAARVEGLSLDISVHSHLQILDEEHTKGKYHHGLSALKPFRTTTKHQHPVDNAGLFSYMTFSWLSPLAQVVHKKGELLMEDVWPLSKYESSDVNCRRLERLWQEELNEVGPDAASLRRVVWIFCRTRLILSIVCLMITQLAGFSGPAFVVKHLLEYTQATESNLQYSLLLVLGLLLTEVVRSWSLALTWALNYRTGVRLRGAVLTMAFKKILKLKNIKEKSLGELINICSNDGQRMFEAAAVGSLLAGGPVVAILGMIYNVIILGPTGFLGSAVFILFYPAMMFVSRLTAYFRRKCVAATDDRVQKMNEVLTYIKFIKMYAWVKAFSQCVQKIREEERRILEKAGYFQSITVGVAPIVVVIASVVTFSVHMTLGFDLTAAQAFTVVTVFNSMTFALKVTPFSVKSLSEASVAVDRFKSLFLMEEVHMIKNKPASPHIKIEMKNATLAWDSSHSSTQSSPKLTPKVKKDKRAPKGKKEKSRQLQHTEHQAVLAEQKGHLLLDSDERPSPEEEEGKQIHAGSMRLQRTLYNIDLEIEEGKLVGICGSVGSGKTSLISAILGQMTLLEGSIAVSGTFAYVAQQAWILNATLRDNILFGKEFDEERYNSVLNSCCLRPDLAILPNSDLTEIGERGANLSGGQRQRISLARALYSDRSIYILDDPLSALDAHVGNHIFNSAIRKRLKSKTVLFVTHQLQYLVDCDEVIFMKEGCITERGTHEELMNLNGDYATIFNNLLLGETPPVEINSKKEASGSQKSQDKGPKPGSVKKEKAVKSEEGQLVQVEEKGQGSVPWSVYWVYIQAAGGPLAFLVIMVLFMLNVGSTAFSTWWLSYWIKQGSGNSTVFEGNRSSVSDSMRDNPFLQYYASIYALSMAVMLILKAIRGVVFVKGTLRASSRLHDELFRRILRSPMKFFDTTPTGRILNRFSKDMDEVDVRLPFQAEMFIQNVILVFFCVGMIAGVFPWFLVAVGPLLILFSVLHIVSRVLIRELKRLDNITQSPFLSHITSSIQGLATIHAYNKRQEFLHRYQELLDDNQAPFFLFTCAMRWLAVRLDLISIALITTTGLMIVLMHGQIPSAYAGLAISYAVQLTGLFQFTVRLASETEARFTSVERINHYIKTLSLEAPARIKNKAPPHDWPQEGEITFENAEMRYRENLPLVLKKVSFTIKPKEKIGIVGRTGSGKSSLGMALFRLVELSGGCIKIDGVRISDIGLADLRSKLAIIPQEPVLFSGTVRSNLDPFNQYTEEQIWDALERTHMKECIAQLPLKLESEVMENGDNFSVGERQLLCIARALLRHCKILILDEATAAMDTETDLLIQETIREAFADCTMLTIAHRLHTVLGSDRIMVLAQGQVVEFDTPSVLLSNDSSRFYAMCAAAENKVAVKG | Rat | Not specified | Not specified | Not found | Not found | Not found |
| dbacp01589 | BCP-A | WPP | Marine invertebrates | Inducing apoptosis | Not specified | PC-3 | Not specified | IC50 : 1.99 mg/ml |
| dbacp01590 | BCP-A | WPP | Marine invertebrates | Inducing apoptosis | Not specified | DU-145 | Not specified | IC50 : 2.80 mg/ml |
| dbacp01591 | BCP-A | WPP | Marine invertebrates | Inducing apoptosis | Not specified | H1299 | Not specified | IC50 : 3.3 mg/ml |
| dbacp01592 | BCP-A | WPP | Marine invertebrates | Inducing apoptosis | Not specified | HeLa | Not specified | IC50 : 2.54 mg/ml |
| dbacp02572 | Crotalicidin | KRFKKFFKKVKKSVKKRLKKIFKKPMVIGVTIPF | Venom gland, South American pit vipers,South American rattlesnake | Cytoxicity activity | Not specified | Not found | Not found | Not found |
| dbacp02573 | Crotalicidin | MQGFFWKTWLVLAVCGTPASLAHRPLSYGEALELAVSVYNGKAGEASLYRLLEAVPQPEWDPSSEGSQQLNFTLKETACQVEEERSLEECGFQEDGVVLECTGYYFFGETPPVVVLSCVPVGGVEEEEEEEEEEQKAEAENDEEVEKEKGDEEKDQPKRVKRFKKFFKKVKKSVKKRLKKIFKKPMVIGVTIPF | South American rattlesnake | Cytoxicity activity | Not specified | Not found | Not found | Not found |
| dbacp02574 | Crotamine | YKQCHKKGGHCFPKEKICLPPSSDFGKMDCRWRWKCCKKGSG | rattlesnake venom,South American rattlesnake | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp02575 | Crotamine | FIQHLIPLIPHAIQGIKDIF-NH2 | South American rattlesnake | Permeabilization of lysosomes; Release of Ca2+ from endoplasmic reticulum; Destruction of mitochondrial membrane potential | Not specified | Not found | Mouse melanoma | Not found |
| dbacp02576 | Crotamine | YKQCHKKGGHCFPKEKICLPPSSDFGKMDCRWRWKCCKKGSG | Venom,South American rattlesnake | Cell membrane disintegration | Not specified | Not found | Breast cancer | Not found |
| dbacp02577 | Crotamine | MKILYLLFAFLFLAFLSEPGNAYKQCHKKGGHCFPKEKICLPPSSDFGKMDCRWRWKCCKKGSGK | South American rattlesnake | Cell membrane penetration and lysis | MTT assay | CHO-K1 | Not specified | IC50 : 5 μM |
| dbacp02580 | CS5931 | MVVCPDGQSECPDGN | Marine invertebrates | Inducing apoptosis | Not specified | HCT-8 | Colorectal cancer | Not found |
| dbacp03034 | Galaxamide derivative (Compound 3) | cyclo(WnMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | HepG2 | Breast cancer | IC50 : 3.98 ± 0.71 μg/mL |
| dbacp03035 | Galaxamide derivative (Compound 3) | cyclo(WnMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | MCF-7 | Breast cancer | IC50 : 1.72 ± 0.85 μg/mL |
| dbacp03036 | Galaxamide derivative (Compound 3) | cyclo(WnMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | HeLa | Breast cancer | IC50 : 5.32 ± 0.42 μg/mL |
| dbacp03037 | Galaxamide derivative (Compound 3) | cyclo(WnMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | MD-MBA-231 | Breast cancer | IC50 :3.51 ± 1.32 μg/Ml |
| dbacp03038 | Galaxamide derivative Compound 1 | cyclo(FnMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | HepG2 | Breast cancer | IC50 : 6.25 ± 1.03 μg/mL |
| dbacp03039 | Galaxamide derivative Compound 1 | cyclo(FnMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | MCF-7 | Breast cancer | IC50 : 4.76 ± 1.36 μg/mL |
| dbacp03040 | Galaxamide derivative Compound 1 | cyclo(FnMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | HeLa | Breast cancer | IC50 : 13.22 ± 1.12 μg/mL |
| dbacp03041 | Galaxamide derivative Compound 1 | cyclo(FnMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | MD-MBA-231 | Breast cancer | IC50 : 5.83 ± 0.45 μg/M |
| dbacp03042 | Galaxamide derivative Compound 2 | cyclo(NAl-nMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | HepG2 | Breast cancer | IC50 : 8.42 ± 1.82 μg/mL |
| dbacp03043 | Galaxamide derivative Compound 2 | cyclo(NAl-nMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | MCF-7 | Breast cancer | IC50 : 3.16 ± 0.92 μg/mL |
| dbacp03044 | Galaxamide derivative Compound 2 | cyclo(NAl-nMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | HeLa | Breast cancer | IC50 : 6.43 ± 1.20 μg/mL |
| dbacp03045 | Galaxamide derivative Compound 2 | cyclo(NAl-nMLLLnML) | Marine invertebrates | Inducing apoptosis | MTT assay | MD-MBA-231 | Breast cancer | IC50 : 4.48 ± 2.24 μg/mL |
| dbacp03055 | Geranylgeranyl transferase type-1 subunit beta | MAATEDDRLAGSGEGERLDFLRDRHVRFFQRCLQVLPERYSSLETSRLTIAFFALSGLDMLDSLDVVNKDDIIEWIYSLQVLPTEDRSNLDRCGFRGSSYLGIPFNPSKNPGTAHPYDSGHIAMTYTGLSCLIILGDDLSRVDKEACLAGLRALQLEDGSFCAVPEGSENDMRFVYCASCICYMLNNWSGMDMKKAISYIRRSMSYDNGLAQGAGLESHGGSTFCGIASLCLMGKLEEVFSEKELNRIKRWCIMRQQNGYHGRPNKPVDTCYSFWVGATLKLLKIFQYTNFEKNRNYILSTQDRLVGGFAKWPDSHPDALHAYFGICGLSLMEESGICKVHPALNVSTRTSERLRDLHQSWKTKDSKQCSDNVHISS | Rat | Membrane disruption | Not specified | Not found | Not found | Not found |
| dbacp03281 | hBD-1 | DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK | Keratinocytes; skin; platelets; Human | Cell membrane disintegration | Not specified | Not found | Fibrosarcoma | Not found |
| dbacp03282 | hBD-1 | DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK | Airway, hemofiltrates, urine, kidney; keratinocytes; skin; platelets; oral saliva; milk, mammary gland epithelium, colonic mucosa, Human | Cell membrane disintegration | Not specified | Not found | Fibrosarcoma | Not found |
| dbacp03383 | Interferon gamma (IFN-gamma) | MNATHCILALQLFLMAVSGCYCHGTVIESLESLNNYFNSSGIDVEEKSLFLDIWRNWQKDGDMKILQSQIISFYLRLFEVLKDNQAISNNISVIESHLITTFFSNSKAKKDAFMSIAKFEVNNPQVQRQAFNELIRVVHQLLPESSLRKRKRSRC | Rat | Not specified | Not specified | Not found | Not found | Not found |
| dbacp03384 | Interferon gamma (IFN-gamma) | MSATRRVLVLQLCLMALSGCYCQGTLIESLESLKNYFNSSSMDAMEGKSLLLDIWRNWQKDGNTKILESQIISFYLRLFEVLKDNQAISNNISVIESHLITNFFSNSKAKKDAFMSIAKFEVNNPQIQHKAVNELIRVIHQLSPESSLRKRKRSRC | Rat | Not specified | Not specified | Not found | Not found | Not found |
| dbacp03392 | Interferon gamma (IFN-gamma) | MKYTSSFLAFQLCIILGFSTYYCESRFTKEINILKDYFNASSSDVGDNGTLFVGILKNCQEESDKKIFQSQIVSFYFKLFEKSGGNQIVQKSMDTIKEDIIAKFFHSNSSKLDVFQSLTRISVDNVDFQRRAIIELKKVMDDLSPNQRKRRRSQMLFRGRRASK | Not foundked mole rat | Not specified | Not specified | Not found | Not found | Not found |
| dbacp03409 | Interferon gamma (IFN-gamma) | MSATRRVLVLQLCLMALSGCYCQGTLIESLESLKNYFNSSSMDAMEGKSLLLDIWRNWQKDGNTKILESQIISFYLRLFEVLKDNQAISNNISVIESHLITNFFSNSKAKKDAFMSIAKFEVNNPQIQHKAVNELIRVIHQLSPESSLRKRKRSRC | Rat | Immunomodulatory activity | Not specified | Not found | Not found | Not found |
| dbacp04317 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | HeLa | Cervical cancer | Not found |
| dbacp04318 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | HeLa | Esophageal cancer | Not found |
| dbacp04319 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | HeLa | Liver cancer | Not found |
| dbacp04320 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | HeLa | Bladder cancer | Not found |
| dbacp04321 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | EC109 | Cervical cancer | Not found |
| dbacp04322 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | EC109 | Esophageal cancer | Not found |
| dbacp04323 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | EC109 | Liver cancer | Not found |
| dbacp04324 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | EC109 | Bladder cancer | Not found |
| dbacp04325 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | HepG2 | Cervical cancer | Not found |
| dbacp04326 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | HepG2 | Esophageal cancer | Not found |
| dbacp04327 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | HepG2 | Liver cancer | Not found |
| dbacp04328 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | HepG2 | Bladder cancer | Not found |
| dbacp04329 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | EJ | Cervical cancer | Not found |
| dbacp04330 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | EJ | Esophageal cancer | Not found |
| dbacp04331 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | EJ | Liver cancer | Not found |
| dbacp04332 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | EJ | Bladder cancer | Not found |
| dbacp04333 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | THLE-3 | Cervical cancer | Not found |
| dbacp04334 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | THLE-3 | Esophageal cancer | Not found |
| dbacp04335 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | THLE-3 | Liver cancer | Not found |
| dbacp04336 | LvHemB1 | DVNFLLHKIYGNIRY | Marine invertebrates | Inducing apoptosis | MTT assay | THLE-3 | Bladder cancer | Not found |
| dbacp04626 | MBD-2 | CHTNGGYCVRAICPPSARRPGSCFPEKNPCCKYM | Rat | Not specified | Not specified | Not found | Not found | Not found |
| dbacp04627 | MBD-2 (Murine beta-defensin 2a) | CHTNGGYCVRAICPPSARRPGSCFPEKNPCCKYM | Rat | Not specified | Not specified | Not found | Not found | Not found |
| dbacp04697 | Mouse beta-defensin-14 | FLPKTLRKFFCRIRGGRCAVLNCLGKEEQIGRCSNSGRKCCRKKK | Spleen, colon, and tissues of the upper and lower respiratory tract, Rat | Not specified | Not specified | Not found | Not found | Not found |
| dbacp05089 | P6 | WYIRKIRRFFKWLKKKLKKK | Marine invertebrates | Inducing apoptosis | MTT assay | HT-29 | Colorectal cancer | Not found |
| dbacp05090 | P6 | WYIRKIRRFFKWLKKKLKKK | Marine invertebrates | Inducing apoptosis | MTT assay | DLD-1 | Colorectal cancer | Not found |
| dbacp05091 | P6 | WYIRKIRRFFKWLKKKLKKK | Marine invertebrates | Inducing apoptosis | MTT assay | HCT116 | Colorectal cancer | Not found |
| dbacp05092 | P6 | WYIRKIRRFFKWLKKKLKKK | Marine invertebrates | Inducing apoptosis | MTT assay | SW-620 | Colorectal cancer | Not found |
| dbacp05093 | P6 | WYIRKIRRFFKWLKKKLKKK | Marine invertebrates | Inducing apoptosis | MTT assay | L02 | Colorectal cancer | Not found |
| dbacp05244 | Pentapeptide (ILYMP) | ILYMP | Marine invertebrates | Inducing apoptosis | MTT assay | DU-145 | Prostate cancer | IC50 :11.25 mM |
| dbacp05462 | Peptidoglycan recognition protein 1 | MLFAWAPFPALLGLADSCCFVVPRSEWKALPSECSKGLKKPVRYVVISHTAGSFCSSPDSCEQQARNVQLYQMKQLGWCDVAYNFLIGEDGHVYEGRGWTIKGDHTGPIWNPMSIGITFMGDYSHRVPAKRALRAALNLLKCGVSEGFLRSNYEVKGHRDVQSTLSPGDQLYEIIQSWDHYRE | Rat | Apoptosis inducing | Not specified | L929 | Not found | Not found |
| dbacp05651 | Protein farnesyltransferase subunit beta | MASSSSFTYYCPPSSSPVWSEPLYSLRPEHARERLQDDSVETVTSIEQAKVEEKIQEVFSSYKFNHLVPRLVLQREKHFHYLKRGLRQLTDAYECLDASRPWLCYWILHSLELLDEPIPQIVATDVCQFLELCQSPDGGFGGGPGQYPHLAPTYAAVNALCIIGTEEAYNVINREKLLQYLYSLKQPDGSFLMHVGGEVDVRSAYCAASVASLTNIITPDLFEGTAEWIARCQNWEGGIGGVPGMEAHGGYTFCGLAALVILKKERSLNLKSLLQWVTSRQMRFEGGFQGRCNKLVDGCYSFWQAGLLPLLHRALHAQGDPALSMSHWMFHQQALQEYILMCCQCPAGGLLDKPGKSRDFYHTCYCLSGLSIAQHFGSGAMLHDVVMGVPENVLQPTHPVYNIGPDKVIQATTHFLQKPVPGFEECEDAVTSDPATD | Rat | Anti-proliferative effect | Formate dehydrogenase–coupled PDF assay, Thymidine incorporation assay | HL60 | Leukemia | IC50 : 9.3 ± 2.9 μM |
| dbacp05652 | Protein farnesyltransferase subunit beta | MASSSSFTYYCPPSSSPVWSEPLYSLRPEHARERLQDDSVETVTSIEQAKVEEKIQEVFSSYKFNHLVPRLVLQREKHFHYLKRGLRQLTDAYECLDASRPWLCYWILHSLELLDEPIPQIVATDVCQFLELCQSPDGGFGGGPGQYPHLAPTYAAVNALCIIGTEEAYNVINREKLLQYLYSLKQPDGSFLMHVGGEVDVRSAYCAASVASLTNIITPDLFEGTAEWIARCQNWEGGIGGVPGMEAHGGYTFCGLAALVILKKERSLNLKSLLQWVTSRQMRFEGGFQGRCNKLVDGCYSFWQAGLLPLLHRALHAQGDPALSMSHWMFHQQALQEYILMCCQCPAGGLLDKPGKSRDFYHTCYCLSGLSIAQHFGSGAMLHDVVMGVPENVLQPTHPVYNIGPDKVIQATTHFLQKPVPGFEECEDAVTSDPATD | Rat | Anti-proliferative effect | Formate dehydrogenase–coupled PDF assay, Thymidine incorporation assay | Daudi lymphoma cells | Lymphoma | IC50 : 5.2 ± 2.2 μM |
| dbacp05653 | Protein farnesyltransferase subunit beta | MASSSSFTYYCPPSSSPVWSEPLYSLRPEHARERLQDDSVETVTSIEQAKVEEKIQEVFSSYKFNHLVPRLVLQREKHFHYLKRGLRQLTDAYECLDASRPWLCYWILHSLELLDEPIPQIVATDVCQFLELCQSPDGGFGGGPGQYPHLAPTYAAVNALCIIGTEEAYNVINREKLLQYLYSLKQPDGSFLMHVGGEVDVRSAYCAASVASLTNIITPDLFEGTAEWIARCQNWEGGIGGVPGMEAHGGYTFCGLAALVILKKERSLNLKSLLQWVTSRQMRFEGGFQGRCNKLVDGCYSFWQAGLLPLLHRALHAQGDPALSMSHWMFHQQALQEYILMCCQCPAGGLLDKPGKSRDFYHTCYCLSGLSIAQHFGSGAMLHDVVMGVPENVLQPTHPVYNIGPDKVIQATTHFLQKPVPGFEECEDAVTSDPATD | Rat | Anti-proliferative effect | Formate dehydrogenase–coupled PDF assay, Thymidine incorporation assay | HEK293 | Renal cancer | IC50 : > 250μM |
| dbacp05654 | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | MAATEGVGESAPGGEPGQPEQPPPPPPPPPAQQPQEEEMAAEAGEAAASPMDDGFLSLDSPTYVLYRDRAEWADIDPVPQNDGPSPVVQIIYSEKFRDVYDYFRAVLQRDERSERAFKLTRDAIELNAANYTVWHFRRVLLRSLQKDLQEEMNYIIAIIEEQPKNYQVWHHRRVLVEWLKDPSQELEFIADILNQDAKNYHAWQHRQWVIQEFRLWDNELQYVDQLLKEDVRNNSVWNQRHFVISNTTGYSDRAVLEREVQYTLEMIKLVPHNESAWNYLKGILQDRGLSRYPNLLNQLLDLQPSHSSPYLIAFLVDIYEDMLENQCDNKEDILNKALELCEILAKEKDTIRKEYWRYIGRSLQSKHSRESDIPASV | Rat | Membrane disruption | Not specified | Not found | Not found | Not found |
| dbacp05673 | Protein GPR15LG (Protein GPR15 ligand) (Protein GPR15L) | MRLLTLSGLFFMLFLCLCVLSSEGRKRPAKFPKLRPCCHLSPRSKPITWKGNHTRPCRPCRKLESNSWVVPGALPQI | Rat | Not specified | Not specified | Not found | Not found | Not found |
| dbacp06024 | SCAP1 | LANAK | Marine invertebrates | Inducing apoptosis | Not specified | HT-29 | Not specified | IC50 : 90.31 ± 0.45 μM |
| dbacp06025 | SCAP1 | LANAK | Marine invertebrates | Inducing apoptosis | Not specified | HT-29 | Not specified | IC50 : 70.87 ± 0.82 μM |
| dbacp06026 | SCAP1 | LANAK | Marine invertebrates | Inducing apoptosis | Not specified | HT-29 | Not specified | IC50 : 60.21 ± 0.45 μM |
| dbacp06027 | SCH-P10 | DYVP | Marine invertebrates | Inducing apoptosis | MTT assay | DU-145 | Prostate cancer | IC50 : 1.21 mg/mL |
| dbacp06028 | SCH-P10 | DYVP | Marine invertebrates | Inducing apoptosis | MTT assay | PC-3 | Prostate cancer | IC50 : 1.09 mg/mL |
| dbacp06029 | SCH-P9 | LPGP | Marine invertebrates | Inducing apoptosis | MTT assay | DU-145 | Prostate cancer | IC50 : 1.21 mg/mL |
| dbacp06030 | SCH-P9 | LPGP | Marine invertebrates | Inducing apoptosis | MTT assay | PC-3 | Prostate cancer | IC50 : 1.09 mg/mL |
| dbacp06138 | Solute carrier family 15 member 2 | MNPFQKNESKETLFSPVSTEEMLPRPPSPPKKSPPKIFGSSYPVSIAFIVVNEFCERFSYYGMKAVLTLYFLYFLHWNEDTSTSVYHAFSSLCYFTPILGAAIADSWLGKFKTIIYLSLVYVLGHVFKSLGAIPILGGKMLHTILSLVGLSLIALGTGGIKPCVAAFGGDQFEEEHAEARTRYFSVFYLAINAGSLISTFITPMLRGDVKCFGQDCYALAFGVPGLLMVLALVVFAMGSKMYRKPPPEGNIVAQVIKCIWFALCNRFRNRSGDLPKRQHWLDWAAEKYPKHLIADVKALTRVLFLYIPLPMFWALLDQQGSRWTLQANKMNGDLGFFVLQPDQMQVLNPFLVLIFIPLFDLVIYRLISKCRINFSSLRKMAVGMILACLAFAVAALVETKINGMIHPQPASQEIFLQVLNLADGDVKVTVLGSRNNSLLVESVSSFQNTTHYSKLHLEAKSQDLHFHLKYNSLSVHNDHSVEEKNCYQLLIHQDGESISSMLVKDTGIKPANGMAAIRFINTLHKDLNISLDTDAPLSVGKDYGVSAYRTVLRGKYPAVHCETEDKVFSLDLGQLDFGTTYLFVITNITSQGLQAWKAEDIPVNKLSIAWQLPQYVLVTAAEVMFSVTGLEFSYSQAPSSMKSVLQAAWLLTVAVGNIIVLVVAQFSGLAQWAEFVLFSCLLLVVCLIFSVMAYYYVPLKSEDTREATDKQIPAVQGnMINLETKNTRL | Rat | Membrane disruption via electrochemical proton gradient | Not specified | Not found | Not found | Not found |
| dbacp06422 | UDP-glucuronosyltransferase 1A1 | MSVVCRSSCSLLLLPCLLLCVLGPSASHAGKLLVIPIDGSHWLSMLGVIQQLQQKGHEVVVIAPEASIHIKEGSFYTMRKYPVPFQNENVTAAFVELGRSVFDQDPFLLRVVKTYNKVKRDSSMLLSGCSHLLHNAEFMASLEQSHFDALLTDPFLPCGSIVAQYLSLPAVYFLNALPCSLDLEATQCPAPLSYVPKSLSSNTDRMNFLQRVKnMIIALTENFLCRVVYSPYGSLATEILQKEVTVKDLLSPASIWLMRNDFVKDYPRPIMPnMVFIGGINCLQKKALSQEFEAYVNASGEHGIVVFSLGSMVSEIPEKKAMEIAEALGRIPQTVLWRYTGTRPSNLAKNTILVKWLPQNDLLGHPKARAFITHSGSHGIYEGICNGVPMVMMPLFGDQMDNAKRMETRGAGVTLNVLEMTADDLENALKTVINNKSYKENIMRLSSLHKDRPIEPLDLAVFWVEYVMRHKGAPHLRPAAHDLTWYQYHSLDVIGFLLAIVLTVVFIVYKSCAYGCRKCFGGKGRVKKSHKSKTH | Rat | Not specified | Not specified | Not found | Not found | Not found |
| dbacp06615 | LA3IK | LAIAVK | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 223.6 ± 5.62 µM |
| dbacp06616 | LA3IK | LAIAVK | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MCF-7 | Breast Cancer | IC50 = 90.23 ± 7.32 µM |
| dbacp06617 | LA3IK | LAIAVK | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | PC-3 | Prostate Cancer | IC50 = 321.4 ± 11.79 µM |
| dbacp06618 | LA3IK | LAIAVK | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | DU-145 | Prostate Cancer | IC50 = 335.7 ± 3.09 µM |
| dbacp06619 | D-LA3IK | laiavk | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 197.72 ± 5.42 µM |
| dbacp06620 | D-LA3IK | laiavk | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MCF-7 | Breast Cancer | IC50 = 91.2 ± 8.21 µM |
| dbacp06621 | D-LA3IK | laiavk | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | PC-3 | Prostate Cancer | IC50 = 98.71 ± 6.17 µM |
| dbacp06622 | D-LA3IK | laiavk | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | DU-145 | Prostate Cancer | IC50 = 89.11 ± 8.12 µM |
| dbacp06623 | LA3IK-SCR | LAKAVI | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 243 ± 8.16 µM |
| dbacp06624 | LA3IK-SCR | LAKAVI | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MCF-7 | Breast Cancer | IC50 = 133 ± 9.52 µM |
| dbacp06625 | LA3IK-SCR | LAKAVI | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | PC-3 | Prostate Cancer | IC50 = 319 ± 13.64 µM |
| dbacp06626 | LA3IK-SCR | LAKAVI | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | DU-145 | Prostate Cancer | IC50 = 351.76 ± 7.18 µM |
| dbacp06627 | RP-7 | RPPCVIL | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 139.03 ± 8.41 µM |
| dbacp06628 | RP-7 | RPPCVIL | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MCF-7 | Breast Cancer | IC50 = 110.12 ± 4.23 µM |
| dbacp06629 | RP-7 | RPPCVIL | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | PC-3 | Prostate Cancer | IC50 = 113 ± 8.02 µM |
| dbacp06630 | RP-7 | RPPCVIL | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | DU-145 | Prostate Cancer | IC50 = 120.72 ± 7.08 µM |
| dbacp06631 | D-RP-7 | rppcvil | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 95 ± 7.71 µM |
| dbacp06632 | D-RP-7 | rppcvil | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MCF-7 | Breast Cancer | IC50 = 90 ± 10.31 µM |
| dbacp06633 | D-RP-7 | rppcvil | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | PC-3 | Prostate Cancer | IC50 = 101 ± 5.73 µM |
| dbacp06634 | D-RP-7 | rppcvil | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | DU-145 | Prostate Cancer | IC50 = 121.59 ± 6.56 µM |
| dbacp06635 | RP7 SCR | RPPLVIC | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MDA-MB-231 | Breast Cancer | IC50 = 156 ± 8.15 µM |
| dbacp06636 | RP7 SCR | RPPLVIC | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | MCF-7 | Breast Cancer | IC50 = 150 ± 10.32 µM |
| dbacp06637 | RP7 SCR | RPPLVIC | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | PC-3 | Prostate Cancer | IC50 = 128 ± 11.65 µM |
| dbacp06638 | RP7 SCR | RPPLVIC | Migration and invasion enhancer 1 (MIEN1) | Targeting the MIEN1 signaling pathway | MTT assay | DU-145 | Prostate Cancer | IC50 = 137 ± 5.98 µM |
| dbacp07468 | Protonectin | ILGTILGLLKGL | Parachartergus fraternus | Cell penetration without toxic accumulation | Resazurin dye assay | MM96L | Skin Cancer | CC50 = 14.8 ± 0.9 µM |
| dbacp07469 | Protonectin | ILGTILGLLKGL | Parachartergus fraternus | Cell penetration without toxic accumulation | Resazurin dye assay | HCT-116 | Colon Cancer | CC50 = 8.0 ± 0.5 µM |
| dbacp07848 | Carnosine | (Beta-A)H | Muscular and Nervous tissues of vertebrates | Inhibits VEGFR-2 angiogenic signaling | MTT assay | MGH-U1 (EJ) | Bladder Cancer | IC50 = 50 mM |
| dbacp08054 | CyO4 | GIPCGESCVWIPCISSAIGCSCKNKVCYRN | Viola odorata | Cyclotides induce cytotoxicity, inhibit migration | MTS assay | MDA-MB-231 | Breast Cancer | IC50 = 9.8 μM |